What Work Has Been Done With Converting Novel Cannabinoids for Therapeutic Research? Mark Scialdone @medicinal.genomics
What Work Has Been Done With Converting Novel Cannabinoids for Therapeutic Research? Mark Scialdone  @medicinal.genomics
Uploaded July 2025 | Updated September 2026, 2 weeks ago
Dr. Mark Scialdone is a recognized expert in the field of organic chemistry, specializing in natural product chemistry, including plant oil extraction, analysis, and chemical modification. He is an inventor of 37 issued US patents and has authored 17 peer-reviewed publications, during more than two decades of fundamental and product development research. He has given numerous invited lectures at more than 40 different academic institutions and international symposia.

At CannMed 25, Mark participated in the Hemp-Derived Cannabinoids panel, which explored the rapid rise of products containing chemically transformed cannabinoids to exploit the 2018 Farm Bill loophole. He also presented a poster that explained the process for chemically converting cannabinoids in more detail.

During our conversation we discussed:

* Why producers and manufacturers would want to convert one cannabinoid into another
* Common methods for cannabinoid conversion
* Safety risks associated with chemical cannabinoid conversion
* The legality of these compounds
* How these compouns and these products are affecting the legal cannabis market
* The therapeutic potential of novel, chemically-converted cannabinoids
* and more

Thanks to This Episode’s Sponsor: Cannabis & Tech Today

Cannabis & Tech Today is the premier publication for the business, science, and innovations shaping the cannabis industry. From exclusive interviews with industry leaders to deep dives on the latest tech, they cover it all.

Go to cannatechtoday.com to subscribe to their digital and print editions and gain access to exclusive interviews, brand-new technology, and thought-provoking articles from every corner of the cannabis community.

Additional Resources
* Pre-Register for CannMed 26 for just $100 (cvent.me/ryXrgZ)
* CannMed Video Archive (cannmedevents.com/cannmed-video-archives/)
* Connect with Mark on LinkedIn (linkedin.com/in/mark-scialdone-0247625b/)
* The Dark Side of Cannabidiol (CBD): The Unanticipated Social and Clinical Implications of Synthetic Δ8-THC (pubmed.ncbi.nlm.nih.gov/36264171/)
* Hash Church on YouTube (youtube.com/playlist?list=PL668WdsJxoe3m1XJPFCBQ2h4JUy8ulCLx)
* CANN Delta-8-THC Panel Discussion (youtu.be/rdbQXLfKREg?si=Rrrk7gKpC4fH2ELJ)
* GC Separation for Identification of iso-THC Contaminants and Accurate Quantification of Δ8 -THC and Δ9-THC in Cannabis Samples (caymanchem.com/literature/GC-Identification-of-iso-THC-Contaminants?srsltid=AfmBOoqiSA7-_N7g0lObACmVbGrCjyY3yrbCscyNkuDBws-o-_4-fId5)
What Work Has Been Done With Converting Novel Cannabinoids for Therapeutic Research? Mark ScialdoneHow Would Rescheduling THC to Schedule III Impact Clinical Trials?How cold do you go for butane extraction?Deprescribing Patterns After Medical Cannabis Initiation in Older Adults with PolypharmacyA Look Under the Microscope, Hidden Spores in Cannabis Flowers!White Spots on Your Cannabis Plants? Watch ThisProduct Development & Your Testing Lab!Insights on Medical Cannabis Patient Demographics!Bridging the Gap: New Findings on the Utility of CBG-Dominant and THC-Containing Hemp ProductsWhat real world problems, inspired you to start looking at butane temperature effects? - Manuel SosaDecoding Natural Hop Latent Viroid Tolerance with Ansley BurtchCannabinoids in Sports and Recovery: Emerging Science and Clinical Applications: Bonni Goldstein
Medicinal Genomics |

What Work Has Been Done With Converting Novel Cannabinoids for Therapeutic Research? Mark Scialdone

SHARE TO X SHARE TO REDDIT SHARE TO FACEBOOK WALLPAPER